Drug Addiction Treatment Market it Would Grow up to USD 30,789.21 Million by 2030
Clients accomplish unparalleled insights and acquaintance of the best market opportunities into their respective markets from Global Drug Addiction Treatment Market analysis report. It is a professional and in depth market report that focuses on primary and secondary drivers, market share, possible sales volume, leading segments and geographical analysis of HELATH industry. The data and information included in this report are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. The market data is analysed and forecasted using well established market statistical and coherent models.
Data Bridge Market Research analyses a growth rate in the drug addiction treatment market in the forecast period 2023-2030. The expected CAGR of drug addiction treatment market is tend to be around 7.3% in the mentioned forecast period. The market was valued at USD 17522.69 million in 2022, and it would grow up to USD 30,789.21 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-addiction-treatment-market&Shri
Drug overdose is among the top causes of mortality globally. According to records of Centers for Disease Control and Prevention (CDC), more than 91,000 individuals died in 2020 because of drug overdose in the U.S. Several responses of governments provide a multitude of unique perspectives on how to manage the addicts, eliminate stigma linked with substance usage, and starve the underground markets. Numerous companies are advancing medicinal therapy’s use to treat opioid-use disorders in novel and more efficient ways.
Market Definition
Drug addiction is also known as substance use disorder, a mental health disorder wherein a patient cannot control the use of drugs or any medications or substance. Drug addiction treatment is meant to help patients to limit the use of abuse drugs. Drug abuse is when an individual consumes legal or illegal substances. Whereas addiction is when an individual fails in discontinuing the consumption of these drugs.
Drivers
- Growing Awareness about Drug addiction
To increase the customer pool, drug abuse treatment providers and manufacturers primarily focus on creating awareness among people and drug store owners about the severe effects of drug abuse and the importance of abuse treatment. Increasing awareness through television advertisements, information brochures, newspapers, and other media has proved to be very effective in impeding the substance abuse crisis to a certain extent.
- Growing Partnerships Between Organizations
There are several organizations that are participating in several organizations that are boosting the growth of the market. For instance, in March 2016, GlaxoSmithKline partnered with 2morrow Inc., developer of SmartQuit app to supply patches to smokers having the app plan. In August 2013, the company agreed with Amneal Pharmaceuticals LLC to distribute its Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets (CIII), a generic version of Suboxon, to addiction treatment centers.
Opportunities
- Stress on Addiction Treatment Laboratories
The addiction crisis over the past decade has augmented the need to invest in integrated R&D activities which focus on addiction treatment and the recovery process. Although the number of research activities pertaining to issues related to addiction has increased at an impressive pace, stakeholders operating in the current addiction treatment market landscape are progressively finding new methods to implement these findings into the real-world care delivery.
Recent Development:
- On 2022, Pfizer, Inc. announced a new strategic partnership with Alex Therapeutics to customize treatment through digital therapeutics and use AI-based platform of the latter company for providing Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) to patients of nicotine addiction.
- On 2022, Indivior PLC. entered into a collaborative agreement with Addex Therapeutics, a clinical-stage pharmaceutical company, for discovery and development of novel oral gamma-aminobutyric acid subtype B (GABAB) Positive Allosteric modulator (PAM) drug candidates. Under this agreement, Indivior will provide the latter company with round USD 900,000 as additional research funding.
Some of the major players operating in the gamma-aminobutyric acid (GABA) receptor agonist market are Sanofi, Mylan N.V., Teva Pharmaceutical Industries Ltd, Novartis AG, Aytu BioScience, Inc., Dr. Reddy’s Laboratories Ltd, Endo Pharmaceuticals Inc., Lupin, Johnson & Johnson Services, Inc, Lannett, Sun Pharmaceutical Industries Ltd, Cipla Inc, Aurobindo Pharma and Zydus Cadila among others.
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-drug-addiction-treatment-market?Shri
This Market Intelligence Report Analyses Some of the Most Crucial Concerns:
- How will the major segments of this international market develop over the next few years?
- Who are the major players that will dominate the market in the future?
- When it comes to this industry, who are the top suppliers and producers?
- How have the most successful companies in the industry planned for future growth and expansion?
- In what sectors might we expect to see the greatest increase in demand over the coming years?
- How many distinct subsets of buyers make up this market?
- Which regional powerhouse do you foresee as becoming the largest player in the international market?
- Does a new coronavirus pandemic have any consequences?
- In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?
Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Scope
The gamma-aminobutyric acid (GABA) receptor agonist market is segmented on the basis of indication, drugs, therapeutics, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Insomnia
- Epilepsy
- Spasticity
- Anxiety
- Others
On the basis of indication, the gamma-aminobutyric acid (GABA) receptor agonist market is segmented into insomnia, epilepsy, spasticity, anxiety and others.
Drugs
- Zolpidem
- Topiramate
- Baclofen
- Others
On the basis of drugs, the gamma-aminobutyric acid (GABA) receptor agonist market is segmented into zolpidem, topiramate, baclofen and others.
Therapeutics
- Bamaluzole
- Phenibut
- Baclofen
- Gaboxadol
On the basis of therapeutics, the gamma-aminobutyric acid (GABA) receptor agonist market is segmented into bamaluzole, phenibut, baclofen and gaboxadol.
Route of Administration
- Oral
- Parenteral
- Intrathecal
- Others
On the basis of route of administration, the gamma-aminobutyric acid (GABA) receptor agonist market is segmented into oral, parenteral, intrathecal and others.
End Users
- Hospitals
- Specialty Clinics
- Others
On the basis of end users, the gamma-aminobutyric acid (GABA) receptor agonist market is segmented into hospitals, specialty clinics and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
The gamma-aminobutyric acid (GABA) receptor agonist market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-drug-addiction-treatment-market&Shri
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
